Presentation The Structural Heart Disease Summit 2018 Recurrent Leaflet Thrombosis After Sapien 3 Valve-in-Valve TAVR Presenter: Howard C. Herrmann, Fabian Nietlispach, Hasan Ahmad, MD June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Societal Impact of Access Restrictions to TAVR: Viewpoint From The Canadian Health Technology Assessment (HTA) Agency Presenter: Randolph P. Martin, Mark J. Russo, Harindra Wijeysundera June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Evolut R Low-Risk Presenter: Jeffrey J. Popma June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Improved Temporary Transvenous Pacemakers: The BioTrace Tempo Lead Presenter: Tamim Nazif, Steven J. Yakubov June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Partner 3 Low-Risk Presenter: Martin B. Leon June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Subtotal Left Main Occlusion Two Days After Transcatheter Aortic Valve Replacement in Severe Bicuspid Aortic Stenosis Presenter: Howard C. Herrmann, Fabian Nietlispach, Futoshi Yamanaka, MD June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Cases of Unusual Mechanisms of Coronary Occlusion During TAVR Presenter: Omar Khalique June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Coronary Occlusion Following Self-Expandable Transcatheter Aortic Valve Replacement in Native Aortic Valve Regurgitation Presenter: Howard C. Herrmann, Fabian Nietlispach, Mohamad Lazkani, MD June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Large Hole Transfemoral Closure III: The MANTA Device Presenter: Nicolas M. Van Mieghem June 21, 2018
Presentation The Structural Heart Disease Summit 2018 TAVR Case Selection in the Real World: Based on Society Guidelines OR Risk Models OR Clinical and Anatomic Factors? Presenter: Allan Schwartz, Stephan Windecker, Neil E. Moat June 21, 2018
Presentation The Structural Heart Disease Summit 2018 The New Syndrome of Delayed Coronary Occlusion (DCA) After TAVR: Frequency, Causes, and Outcomes Presenter: Azeem Latib June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Large Hole Transfemoral Closure II: The InSeal Device Presenter: Ran Kornowski June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Acute Left Main Stem Coronary Occlusion Following Transcatheter Aortic Valve Replacement in a Patient Without Recognized Coronary Obstruction Risk Factors Presenter: Howard C. Herrmann, Fabian Nietlispach, Roberto Spina, MD June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Large Hole Transfemoral Closure I: The PerQseal Device Presenter: Jeffrey J. Popma June 21, 2018
Presentation The Structural Heart Disease Summit 2018 TAVR Outcomes for Bicuspid Aortic Valve Disease in Asian Patients Presenter: John C Laschinger, Mathew Williams, Jung-Min Ahn June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Incidence, Predictors, Consequences, Prevention, and Treatment of Coronary Occlusion During TAVR: Practical Clinical Guidelines Presenter: Ariel Finkelstein June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Periprocedural Transaortic Valve LVOT Migration With Successful Reposition: "The Double-Snare Technique Presenter: Howard C. Herrmann, Fabian Nietlispach, Matja Bunc, MD June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Instructive Case Examples: A Tale of Three Bicuspids To Treat or Not to Treat? Presenter: John C Laschinger, Mathew Williams, Hasan Jilaihawi June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Hybrid Beating Coronary Artery Bypass Grafting and Transcatheter Aortic Valve Replacement via Right Carotid Artery Access in a Patient With Severe Peripheral Arterial Disease Presenter: Howard C. Herrmann, Fabian Nietlispach, Marc Gerdisch, MD June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Techniques to Reduce the Frequency of Pacemaker Implantation After TAVR Presenter: Hemal Gada June 21, 2018